Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: A body mass index-independent role of adiponectin?

Journal of Endocrinological Investigation

Volumn 36, Issue 1, 2013, Pages 1-6

  Al Daghri, N M ^a,b,c   Al Attas, O S ^a,b,c   Alokail, M S ^a,b,c   Alkharfy, K M ^a,b,d   Al Othman, A ^c,e   Draz, H M ^a   Yakout, S M ^a,c   Al Saleh, Y ^c,f   Al Yousef, M ^g   Sabico, S ^a   Clerici, M ^a,h   Chrousos, G P ^a,i  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Center of Excellence in Biotechnology Research   (Saudi Arabia)

^c Biomarkers of Osteoporosis   (Saudi Arabia)

^d Department of Pharmacology and Toxicology   (Saudi Arabia)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

^g MINISTRY OF HEALTH   (Saudi Arabia)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adiponectin; Insulin resistance; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SAUDI ARABIA; VITAMIN D DEFICIENCY;

ADIPOKINES; ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; PROGNOSIS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84873594013     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8183     Document Type: Article

References (30)

1. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92: 2017-29.
2. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209: 823-5.
3. Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF. Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983, 113: 1511-8.
4. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986, 119: 84-90.
5. Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 1984, 73: 759-66.
6. Nyomba BL, Bouillon R, De Moor P. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 1984, 115: 191-7.
7. Tanaka Y, Seino Y, Ishida M, et al. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol (Copenh) 1984, 105: 528-33.
8. Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008, 10: 185-97.
9. Maalouf G, Gannagé-Yared MH, Ezzedine J, et al. Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 2007, 7: 131-43.
10. Al-Turki HA, Sadat-Ali M, Al-Elq AH, Al-Mulhim FA, Al-Ali AK. 25-Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Med J 2008, 29: 1765-8.
11. Sedrani SH, Elidrissy AW, El Arabi KM. Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr 1983, 38: 129-32.
12. Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) 2012, 76: 346-50.
13. Al-Atawi MS, Al-Alwan IA, Al-Mutair AN, Tamim HM, Al-Jurayyan NA. Epidemiology of nutritional rickets in children. Saudi J Kidney Dis Transpl 2009, 20: 260-5.
14. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79: 820-5.
15. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57: 258-61.
16. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009, 36: 205-10.
17. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28: 1228-30.
18. Umeda M, Ichikawa S, Kanda T, Sumino H, Kobayashi I. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am J Hypertens 2001, 14: 206-11.
19. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48: 1247-57.
20. Lind L, Hänni A, Lithell H, Hvarfner A, Sörensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995, 8: 894-901.
21. Petchey WG, Hickman IJ, Duncan E, et al. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol 2009, 10: 41.
22. Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 2005, 62: 738-41.
23. Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009, 139: 329-34.
24. Muscogiuri G, Sorice GP, Prioletta A, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes: comment to Kayaniyil et al. Diabetes Care 2010, 33: e99-100.
25. Muscogiuri G, Sorice GP, Prioletta A et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 2010, 18: 1906-10.
26. Bindal ME, Taskapan H. Hypovitaminosis D and insulin resistance in peritoneal dialysis patients. Int Urol Nephrol 2011, 43: 527-34.
27. Gannage-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009, 160: 965-71.
28. Holland WL, Miller RA, Wang ZV et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011, 17: 55-63.
29. Manggau M, Kim DS, Ruwisch L et al. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 2001, 117: 1241-9.
30. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002, 277: 37487-91.